시장보고서
상품코드
1771706

수술용 가운 레벨 AAMI 3 시장 : 시장 규모, 점유율, 동향 분석 - 가운 유형별, 수술별, 사용성별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Surgical Gowns Level AAMI 3 Market Size, Share & Trends Analysis By Gown Type (Fabric Reinforced, Non-fabric Reinforced), By Surgery (Orthopedic Surgery, General Surgery), By Usability, By End Use, By Region, And Segment Forecasts, 2025 - 2033

발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 110 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

수술용 가운 레벨 AAMI 3 시장 요약

세계의 수술용 가운 레벨 AAMI 3시장 규모는 2024년 7억 5,652만 달러로 평가되었고, 2033년 19억 8,577만 달러에 이를 전망이며, 2025-2033년 CAGR 11.27%로 성장할 것으로 예측됩니다. 이 성장의 배경에는 수술 건수 증가, 헬스케어 관련 감염 증가, 세계의 감염 예방 관리 기준의 엄격화가 있습니다.

세계의 인구 고령화는 시장 확대를 더욱 뒷받침하고, 입원 환자나 외래 환자에 있어서의 중간 정도의 배리어 보호 가운 수요 증가, 특히 팬데믹 후의 수술 안전에 대한 의식의 고조가 있습니다. 게다가 가운 소재의 기술 혁신이나 신흥국에서의 헬스케어 인프라 개선이 예측 기간 동안 시장 도입을 더욱 촉진할 것으로 예측되고 있습니다. CDC 조사에 따르면 미국에서는 입원 환자 약 31명 중 1명이 헬스케어 관련 감염병에 이환되고 있으며 연간 환자 수는 63만 3,300명으로 추정됩니다. 2023년 펜실베이니아주 환자안전보고시스템(Patient Safety Reporting System)은 주내 장기케어시설에서 보고된 HAI 사고 2만 3,970건을 기록하여 급성기 및 장기케어 환경에서의 감염관리의 지속적인 과제를 부각시켰습니다.

수술 부위 감염(SSI), 메티실린 내성 스타필로코커스 아우레우스(MRSA), 클로스트리듐 디피실 감염, 중심 정맥 라인 관련 혈류 감염(CLABSI) 등 헬스케어 관련 감염의 발생률 상승은 AAMI 3의 수술용 가운에 대한 수요를 부추기는 중요한 요인입니다. 이러한 감염병은 환자의 안전성을 해치고, 입원 기간의 연장, 이환율의 증가, 헬스케어 비용의 증가로 이어집니다. 그 중에서도 CLABSI는 환자가 중심정맥 카테터와 같은 침습적인 기구를 필요로 하는 외과 및 집중치료 환경에서 특히 우려되고 있습니다. 중간 정도의 장벽 보호 기능을 갖춘 수술용 가운 등의 개인 방호구를 적절하게 사용하는 것은 라인 삽입 시나 외과 처치 시의 오염 위험을 줄이는 데 매우 중요합니다. 이러한 리스크에 대응하기 위해, 헬스케어 시설에서는, CDC, WHO, ECDC의 권고에 근거해, 보다 엄격한 감염 예방 및 관리 프로토콜이 채용되고 있습니다. 쾌적함과 내액성의 균형으로 알려진 AAMI3 가운은 수술실이나 중환자실 등 혈액과 체액에 적당히 노출되는 환경에서 점점 사용되고 있습니다. 특히 항균제 내성 증가를 고려한 HAI 감축에 대한 세계의 초점은 높은 수준의 방호복에 대한 강한 수요를 지속적으로 뒷받침하며 시장을 끌어올리고 있습니다. 호주 보건복지연구소(Australian Institute of Health and Welfare)에 따르면 2023-2024년 전체 공립병원에서 1,699건의 SABSI 증례가 보고돼 2,270만 명의 환자 진료일수에 걸쳐 발생했습니다.

목차

제1장 조사 방법 및 범위

제2장 주요 요약

제3장 수술용 가운 레벨 AAMI 3 시장의 변수, 동향 및 범위

  • 시장 계통 전망
    • 상위 시장 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
    • 시장 기회 분석
    • 시장 과제 분석
  • 수술용 가운 시장 분석 툴
    • 업계 분석-Porter's Five Forces 분석
    • PESTEL 분석

제4장 수술용 가운 레벨 AAMI 3 시장 : 가운 유형별 추정 및 동향 분석

  • 부문 대시보드
  • 세계의 수술용 가운 레벨 AAMI 3 시장 : 가운 유형별 변동 분석
  • 세계의 수술용 가운 레벨 AAMI 3 시장 : 가운 유형별 규모 및 동향 분석(2021-2033년)
  • 직물 보강
  • 비포지 보강

제5장 수술용 가운 레벨 AAMI 3 시장 : 수술별 추정 및 동향 분석

  • 부문 대시보드
  • 세계의 수술용 가운 레벨 AAMI 3 시장 : 수술별 변동 분석
  • 세계의 수술용 가운 레벨 AAMI 3 시장 : 수술별 규모 및 동향 분석(2021-2033년)
  • 정형 외과
  • 일반 외과
  • 부인과 수술
  • 내시경 수술
  • 유방절제술
  • 기타

제6장 수술용 가운 레벨 AAMI 3 시장 : 사용성별 추정 및 동향 분석

  • 부문 대시보드
  • 세계의 수술용 가운 레벨 AAMI 3 시장 : 사용성별 변동 분석
  • 세계의 수술용 가운 레벨 AAMI 3 시장 : 사용성별 규모 및 동향 분석(2021-2033년)
  • 일회용 가운
  • 재사용 가능한 가운

제7장 수술용 가운 레벨 AAMI 3 시장 : 최종 용도별 추정 및 동향 분석

  • 부문 대시보드
  • 세계의 수술용 가운 레벨 AAMI 3 시장 : 최종 용도별 변동 분석
  • 세계의 수술용 가운 레벨 AAMI 3 시장 : 최종 용도별 규모 및 동향 분석(2021-2033년)
  • 수술실
  • 응급 처치실
  • 집중치료실(ICU)
  • 기타

제8장 수술용 가운 레벨 AAMI 3 시장 : 지역별 추정 및 동향 분석

  • 지역 대시보드
  • 시장 규모와 예측 및 동향 분석(2021-2033년)
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 덴마크
    • 스웨덴
    • 노르웨이
  • 아시아태평양
    • 일본
    • 인도
    • 중국
    • 한국
    • 호주
    • 태국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 남아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 쿠웨이트

제9장 경쟁 구도

  • 주요 시장 진출기업에 의한 최근의 동향 및 영향 분석
  • 기업 및 경쟁의 분류
    • 이노베이터
  • 벤더 상황
    • 주요 리셀러 및 채널 파트너 목록
    • Key customers
    • Global Key company market share analysis, 2024
    • Cardinal Health
    • Medline Industries, LP
    • Molnlycke Health Care AB
    • Medicom
    • Encompass Group, LLC.
    • Taromed
    • Cortex Products Solution Pvt. Ltd
    • Nippon Encon Manufacturing Co., Ltd.
    • Owens &Minor
    • Medilivescare Manufacturing Pvt. Ltd.
    • Boston Scientific Corporation
    • Henry Schein, Inc.
    • Standard Textile Co., Inc.
    • Dynarex Corporation
    • Rankinc
    • LDI Solutions, LLC
    • Vannin Healthcare
    • RUHOF
  • 히트맵 분석 및 기업 시장 포지셔닝 분석
  • 기업의 시장 점유율 예측 분석(2024년)
  • 기타 주요 시장 기업 목록
AJY 25.07.23

Surgical Gowns Level AAMI 3 Market Summary

The global surgical gowns level AAMI 3 market size was estimated at USD 756.52 million in 2024 and is projected to reach USD 1,985.77 million by 2033, growing at a CAGR of 11.27% from 2025 to 2033. This growth is attributed to the rising surgical procedure volumes, the increasing prevalence of healthcare-associated infections, and stringent global infection prevention and control standards.

The aging global population further supports the market expansion, the growing demand for moderate barrier protection gowns in inpatient and outpatient settings, and heightened awareness of surgical safety, particularly post-pandemic. In addition, innovation in gown materials and healthcare infrastructure improvements in emerging economies are anticipated to boost market adoption further over the forecast period. According to a study by the CDC, approximately 1 in every 31 hospitalized patients in the U.S. acquires a healthcare-associated infection, translating to an estimated 633,300 cases annually. In 2023, the Pennsylvania Patient Safety Reporting System recorded 23,970 HAI incidents reported by long-term care facilities across the state, highlighting the ongoing challenge of infection control in acute and extended care settings.

The rising incidence of healthcare-associated infections, including Surgical Site Infections (SSIs), Methicillin-Resistant Staphylococcus aureus (MRSA), Clostridium difficile infections, and Central Line-Associated Bloodstream Infections (CLABSIs), is a significant factor fueling the demand for AAMI Level 3 surgical gowns. These infections compromise patient safety, leading to longer hospital stays, increased morbidity, and higher healthcare costs. Among these, CLABSIs are particularly concerning in surgical and intensive care settings, where patients require invasive devices like central venous catheters. Proper use of personal protective equipment, including surgical gowns with moderate barrier protection, is critical in reducing contamination risk during line insertions and surgical procedures. In response to these risks, healthcare institutions are adopting more stringent infection prevention and control protocols supported by CDC, WHO, and ECDC recommendations. AAMI Level 3 gowns, known for their balance of comfort and fluid resistance, are increasingly used in settings with moderate exposure to blood and bodily fluids, including operating rooms and intensive care units. The global focus on reducing HAIs, especially in light of rising antimicrobial resistance, continues to drive strong demand for high-standard protective apparel, boosting the market. According to the Australian Institute of Health and Welfare, 2023-2024, 1,699 SABSI cases were reported across public hospitals, occurring over 22.7 million patient care days, equating to a national rate of 0.75 cases per 10,000 patient days.

The data below highlights the top 15 U.S. states most affected by Central Line-Associated Bloodstream Infections (CLABSIs) in 2022. These high-capacity healthcare hubs perform a significant volume of invasive procedures involving central lines, increasing the risk of bloodstream infections. As a result, hospitals in these states are under greater pressure to implement rigorous infection prevention protocols, including the mandatory use of AAMI Level 3 surgical gowns that offer essential fluid and microbial barrier protection during central line insertions and maintenance.

Global Surgical Gowns Level AAMI 3 Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global surgical gowns level AAMI 3 market report on the basis of gown type, surgery, end use, usability, and region:

  • Gown Type Outlook (Revenue, USD Million; Volume Unit, Price USD; 2021 - 2033)
  • Fabric Reinforced
  • Non-fabric Reinforced
  • Surgery Outlook (Revenue, USD Million; Volume Unit, Price USD; 2021 - 2033)
  • General Surgery
  • Orthopedic Surgery
  • Endoscopic Surgery
  • Gynecological Surgery
  • Mastectomy
  • Others
  • Usability Outlook (Revenue, USD Million; Volume Unit, Price USD; 2021 - 2033)
  • Disposable Gowns
  • Reusable Gowns
  • End Use Outlook (Revenue, USD Million; Volume Unit, Price USD; 2021 - 2033)
  • Operating Room
  • Emergency Room
  • Intensive Care Unit (ICU)
  • Others
  • Regional Outlook (Revenue, USD Million; Volume Unit, Price USD; 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Gown Type
    • 1.1.2. Surgery
    • 1.1.3. Usability
    • 1.1.4. End Use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Surgical Gowns Level AAMI 3 Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing number of surgical procedures
      • 3.2.1.2. Rising burden of healthcare associated infections
      • 3.2.1.3. Introduction of innovative and advanced surgical gowns
      • 3.2.1.4. Rising hospitalization
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Recalls of surgical gowns
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Growing demand for reusable surgical gowns
      • 3.2.3.2. Improvements in public and private healthcare infrastructure
      • 3.2.3.3. Growth potential in emerging economies in the surgical gowns market
      • 3.2.3.4. Development of antimicrobial surgical gowns
    • 3.2.4. Market challenge analysis
      • 3.2.4.1. Potential complications and risks associated with surgical gowns
  • 3.3. Surgical Gowns Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Surgical Gowns Level AAMI 3 Market: Gown Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Surgical Gowns Level AAMI 3 Market Gown Type Movement Analysis
  • 4.3. Global Surgical Gowns Level AAMI 3 Market Size & Trend Analysis, by Gown Type, 2021 to 2033 (USD Million, Volume Unit, Price USD)
  • 4.4. Fabric Reinforced
    • 4.4.1. Fabric reinforced market estimates and forecast 2021 to 2033 (USD Million, Volume Unit, Price USD)
  • 4.5. Non-fabric Reinforced
    • 4.5.1. Non-fabric reinforced market estimates and forecast 2021 to 2033 (USD Million, Volume Unit, Price USD)

Chapter 5. Surgical Gowns Level AAMI 3 Market: Surgery Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Surgical Gowns Level AAMI 3 Market Surgery Movement Analysis
  • 5.3. Global Surgical Gowns Level AAMI 3 Market Size & Trend Analysis, by Surgery, 2021 to 2033 (USD Million, Volume Unit, Price USD)
  • 5.4. Orthopedic Surgery
    • 5.4.1. Orthopedic surgery market estimates and forecast 2021 to 2033 (USD Million, Volume Unit, Price USD)
  • 5.5. General Surgery
    • 5.5.1. General surgery market estimates and forecast 2021 to 2033 (USD Million, Volume Unit, Price USD)
  • 5.6. Gynecological Surgery
    • 5.6.1. Gynecological surgery market estimates and forecast 2021 to 2033 (USD Million, Volume Unit, Price USD)
  • 5.7. Endoscopic Surgery
    • 5.7.1. Endoscopic surgery market estimates and forecast 2021 to 2033 (USD Million, Volume Unit, Price USD)
  • 5.8. Mastectomy
    • 5.8.1. Mastectomy market estimates and forecast 2021 to 2033 (USD Million, Volume Unit, Price USD)
  • 5.9. Others
    • 5.9.1. Other market estimates and forecasts 2021 to 2033 (USD Million, Volume Unit, Price USD)

Chapter 6. Surgical Gowns Level AAMI 3 Market: Usability Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Surgical Gowns Level AAMI 3 Market Usability Movement Analysis
  • 6.3. Global Surgical Gowns Level AAMI 3 Market Size & Trend Analysis, by Usability, 2021 to 2033 (USD Million, Volume Unit, Price USD)
  • 6.4. Disposable Gowns
    • 6.4.1. Disposable gowns market estimates and forecast 2021 to 2033 (USD Million, Volume Unit, Price USD)
  • 6.5. Reusable Gowns
    • 6.5.1. Reusable gowns market estimates and forecast 2021 to 2033 (USD Million, Volume Unit, Price USD)

Chapter 7. Surgical Gowns Level AAMI 3 Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Surgical Gowns Level AAMI 3 Market End Use Movement Analysis
  • 7.3. Global Surgical Gowns Level AAMI 3 Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million, Volume Unit, Price USD)
  • 7.4. Operating Room
    • 7.4.1. Operating room market estimates and forecast 2021 to 2033 (USD Million, Volume Unit, Price USD)
  • 7.5. Emergency Room
    • 7.5.1. Emergency room market estimates and forecast 2021 to 2033 (USD Million, Volume Unit, Price USD)
  • 7.6. Intensive Care Unit (ICU)
    • 7.6.1. Intensive Care Unit (ICU) market estimates and forecast 2021 to 2033 (USD Million, Volume Unit, Price USD)
  • 7.7. Others
    • 7.7.1. Other market estimates and forecast 2021 to 2033 (USD Million, Volume Unit, Price USD)

Chapter 8. Surgical Gowns Level AAMI 3 Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 8.3. North America
    • 8.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million, Volume Unit, Price USD)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Competitive scenario
      • 8.3.2.3. Regulatory framework
      • 8.3.2.4. Reimbursement scenario
      • 8.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Competitive scenario
      • 8.3.3.3. Regulatory framework
      • 8.3.3.4. Reimbursement scenario
      • 8.3.3.5. Canada market estimates and forecasts, 2021 - 2033
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamics
      • 8.3.4.2. Competitive scenario
      • 8.3.4.3. Regulatory framework
      • 8.3.4.4. Reimbursement scenario
      • 8.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Competitive scenario
      • 8.4.1.3. Regulatory framework
      • 8.4.1.4. Reimbursement scenario
      • 8.4.1.5. UK market estimates and forecasts, 2021 - 2033
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. Reimbursement scenario
      • 8.4.2.5. Germany market estimates and forecasts, 2021 - 2033
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Reimbursement scenario
      • 8.4.3.5. France market estimates and forecasts, 2021 - 2033
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Competitive scenario
      • 8.4.4.3. Regulatory framework
      • 8.4.4.4. Reimbursement scenario
      • 8.4.4.5. Italy market estimates and forecasts, 2021 - 2033
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Competitive scenario
      • 8.4.5.3. Regulatory framework
      • 8.4.5.4. Reimbursement scenario
      • 8.4.5.5. Spain market estimates and forecasts, 2021 - 2033
    • 8.4.6. Denmark
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Competitive scenario
      • 8.4.6.3. Regulatory framework
      • 8.4.6.4. Reimbursement scenario
      • 8.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Competitive scenario
      • 8.4.7.3. Regulatory framework
      • 8.4.7.4. Reimbursement scenario
      • 8.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
    • 8.4.8. Norway
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Competitive scenario
      • 8.4.8.3. Regulatory framework
      • 8.4.8.4. Reimbursement scenario
      • 8.4.8.5. Norway market estimates and forecasts, 2021 - 2033
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Competitive scenario
      • 8.5.1.3. Regulatory framework
      • 8.5.1.4. Reimbursement scenario
      • 8.5.1.5. Japan market estimates and forecasts, 2021 - 2033
    • 8.5.2. India
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. Reimbursement scenario
      • 8.5.2.5. India market estimates and forecasts, 2021 - 2033
    • 8.5.3. China
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. Reimbursement scenario
      • 8.5.3.5. China market estimates and forecasts, 2021 - 2033
    • 8.5.4. South Korea
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. Reimbursement scenario
      • 8.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
    • 8.5.5. Australia
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Reimbursement scenario
      • 8.5.5.5. Australia market estimates and forecasts, 2021 - 2033
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Regulatory framework
      • 8.5.6.4. Reimbursement scenario
      • 8.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Competitive scenario
      • 8.6.1.3. Regulatory framework
      • 8.6.1.4. Reimbursement scenario
      • 8.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. Reimbursement scenario
      • 8.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Competitive scenario
      • 8.7.1.3. Regulatory framework
      • 8.7.1.4. Reimbursement scenario
      • 8.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Reimbursement scenario
      • 8.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Competitive scenario
      • 8.7.3.3. Regulatory framework
      • 8.7.3.4. Reimbursement scenario
      • 8.7.3.5. UAE market estimates and forecasts, 2021 - 2033
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Competitive scenario
      • 8.7.4.3. Regulatory framework
      • 8.7.4.4. Reimbursement scenario
      • 8.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Innovators
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Global Key company market share analysis, 2024
    • 9.3.4. Cardinal Health
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Medline Industries, LP
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Molnlycke Health Care AB
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Medicom
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Encompass Group, LLC.
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Taromed
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Cortex Products Solution Pvt. Ltd
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Nippon Encon Manufacturing Co., Ltd.
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Owens & Minor
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. Medilivescare Manufacturing Pvt. Ltd.
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Product benchmarking
      • 9.3.13.4. Strategic initiatives
    • 9.3.14. Boston Scientific Corporation
      • 9.3.14.1. Company overview
      • 9.3.14.2. Financial performance
      • 9.3.14.3. Product benchmarking
      • 9.3.14.4. Strategic initiatives
    • 9.3.15. Henry Schein, Inc.
      • 9.3.15.1. Company overview
      • 9.3.15.2. Financial performance
      • 9.3.15.3. Product benchmarking
      • 9.3.15.4. Strategic initiatives
    • 9.3.16. Standard Textile Co., Inc.
      • 9.3.16.1. Company overview
      • 9.3.16.2. Financial performance
      • 9.3.16.3. Product benchmarking
      • 9.3.16.4. Strategic initiatives
    • 9.3.17. Dynarex Corporation
      • 9.3.17.1. Company overview
      • 9.3.17.2. Financial performance
      • 9.3.17.3. Product benchmarking
      • 9.3.17.4. Strategic initiatives
    • 9.3.18. Rankinc
      • 9.3.18.1. Company overview
      • 9.3.18.2. Financial performance
      • 9.3.18.3. Product benchmarking
      • 9.3.18.4. Strategic initiatives
    • 9.3.19. LDI Solutions, LLC
      • 9.3.19.1. Company overview
      • 9.3.19.2. Financial performance
      • 9.3.19.3. Product benchmarking
      • 9.3.19.4. Strategic initiatives
    • 9.3.20. Vannin Healthcare
      • 9.3.20.1. Company overview
      • 9.3.20.2. Financial performance
      • 9.3.20.3. Product benchmarking
      • 9.3.20.4. Strategic initiatives
    • 9.3.21. RUHOF
      • 9.3.21.1. Company overview
      • 9.3.21.2. Financial performance
      • 9.3.21.3. Product benchmarking
      • 9.3.21.4. Strategic initiatives
  • 9.4. Heat Map Analysis/ Company Market Position Analysis
  • 9.5. Estimated Company Market Share Analysis, 2024
  • 9.6. List of Other Key Market Players
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제